Celerpurus
Durham, US · Founded 2020 · North Carolina corporation
Biotech
Founders & leadership
TF
Thomas FineganExecutive
JC
Jay CroscaddenNamed on SEC filing
Board
PM
Peter MengesBoard director
Reported raises · per SEC filings
Form D private placements$525K disclosed across 2 rounds · 2021–2022
▶$150KraisedJan 2022 · 15 investors · BiotechnologyRule 506(b)
▶$150KraisedJan 2022 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jay CorscaddenExecutive Officer, Director, Promoter
- Thomas FineganExecutive Officer, Director
- Peter MengesDirector
- Offering amount
- $150K
- Amount sold
- $150K
- First sale
- Jan 2022
- Incorporated
- Corporation, North Carolina, 2020
- Federal exemptions
- 06b
▶$375KraisedApr 2021 · 19 investors · BiotechnologyRule 506(b)
▶$375KraisedApr 2021 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jay CroscaddenExecutive Officer, Director, Promoter
- Thomas FineganExecutive Officer, Director
- Peter MengesDirector
- Offering amount
- $375K
- Amount sold
- $375K
- First sale
- Apr 2021
- Incorporated
- Corporation, North Carolina, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Celerpurus raised?
- Celerpurus has disclosed $525K raised across 2 rounds.
- Where is Celerpurus headquartered?
- Celerpurus is headquartered in Durham, US.